APOG
Apogee EnterprisesFNasdaq / Capital Goods
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
APOG vs peer average
15/100
APOG vs. peer average (F vs. C)
Grade spread
A 2 · B 4 · C 1 · F 2
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
MYGN is the first available peer comparator.
Therapeutic biotech moving from development to commercialization; highlights scale and execution differences relevant to valuation.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
APOG
Apogee Enterprises
MYGN
Myriad Genetics
Grade
F
F
Momentum
94
98
Value
71
41
Sentiment
0
8
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs MYGN
APOG / MYGN
Grade Position
Below peers
APOG vs. peer average (F vs. C)
15/100
Momentum
94
MYGNValue
71
APOGSentiment
0
MYGNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs APOG
MYGN is the first peer returned for this comparison set.